학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 12건 | 목록
1~20
Academic Journal
Zatreanu, D.; Robinson, H.M.R.; Alkhatib, O.; Boursier, M.; Finch, H.; Geo, L.; Grande, D.; Grinkevich, V.; Heald, R.A.; Langdon, S.; Majithiya, J.; McWhirter, C.; Martin, N.M.B.; Moore, S.; Neves, J.; Rajendra, E.; Ranzani, M.; Schaedler, T.; Stockley, M.; Wiggins, K.; Brough, R.; Sridhar, S.; Gulati, A.; Shao, N.; Badder, L.M.; Novo, D.; Knight, E.G.; Marlow, R.; Haider, S.; Callen, E.; Hewitt, G.; Schimmel, J.; Prevo, R.; Alli, C.; Ferdinand, A.; Bell, C.; Blencowe, P.; Bot, C.; Calder, M.; Charles, M.; Curry, J.; Ekwuru, T.; Ewings, K.; Krajewski, W.; MacDonald, E.; McCarron, H.; Pang, L.; Pedder, C.; Rigoreau, L.; Swarbrick, M.; Wheatley, E.; Willis, S.; Wong, A.C.; Nussenzweig, A.; Tijsterman, M.; Tutt, A.; Boulton, S.J.; Higgins, G.S.; Pettitt, S.J.; Smith, G.C.M.; Lord, C.J.
Academic Journal
Zatreanu D; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Robinson HMR; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Alkhatib O; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Boursier M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Finch H; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Geo L; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Grande D; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Grinkevich V; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Heald RA; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Langdon S; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Majithiya J; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; McWhirter C; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Martin NMB; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Moore S; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Neves J; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Rajendra E; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Ranzani M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Schaedler T; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Stockley M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Wiggins K; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; Brough R; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Sridhar S; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Gulati A; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Shao N; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Badder LM; The Breast Cancer Now Research Unit, King's College London, London, UK.; Novo D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Knight EG; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Marlow R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Research Unit, King's College London, London, UK.; Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Callen E; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.; Hewitt G; The Francis Crick Institute, London, UK.; Schimmel J; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Prevo R; Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK.; Alli C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Ferdinand A; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Bell C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Blencowe P; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Bot C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Calder M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Charles M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Curry J; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Ekwuru T; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Ewings K; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Krajewski W; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; MacDonald E; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; McCarron H; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Pang L; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Pedder C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Rigoreau L; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Swarbrick M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Wheatley E; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Willis S; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Wong AC; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.; Nussenzweig A; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.; Tijsterman M; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Tutt A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Research Unit, King's College London, London, UK.; Boulton SJ; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; The Francis Crick Institute, London, UK.; Higgins GS; Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK.; Pettitt SJ; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK. Stephen.Pettitt@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Stephen.Pettitt@icr.ac.uk.; Smith GCM; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK. Graeme.Smith@artiospharma.com.; Lord CJ; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK. Chris.Lord@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Chris.Lord@icr.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
S H, Thomas; R C, Cooper; M, Ekwuru; S, Fletcher; J, Gilbody; T S, Husseyin; M, Ishaque; R, Jagathesan; G, Reddy; S E, Smith
European Journal of Clinical Pharmacology. 42:47-53
Stockley ML; Benedetti G; Blencowe P; Boulton SJ; Boyd SM; Calder M; Charles MD; Edwardes LV; Ekwuru T; Ferdinand A; Finch H; Galbiati A; Geo L; Grande D; Grinkevich V; Higgins GS; Holliday ND; Krajewski WW; MacDonald E; Majithiya JB; McCarron H; McWhirter CL; Patel V; Pedder C; Rajendra E; Ranzani M; Rigoreau LJM; Robinson HMR; Schaedler T; Sirina J; Smith GCM; Swarbrick ME; Turnbull AP; Willis S; Zemla A; Heald RA
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Finlay MRV; Anderton M; Bailey A; Boyd S; Brookfield J; Cairnduff C; Charles M; Cheasty A; Critchlow SE; Culshaw J; Debreczeni J; Ekwuru T; Hollingsworth I; Jones N; Leroux F; Littleson M; McCarron H; McKelvie J; Mooney L; Nissink JWM; Patel J; Perkins D; Powell S; Quesada MJ; Raubo P; Sabin V; Smith J; Smith PD; Stark A; Ting A; Wang P; Wilson Z; Winter-Holt JJ; Wood JM; Wrigley GL; Yu G; Zhang P
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: PubMed not MEDLINE; MEDLINE
Book
P. D. Riordan; P. J. Dudfield; G. G. Briggs; C. T. Ekwuru; C. E. Osbourn; K. Hamilton; D. J. Simpson
ACS Symposium Series ISBN: 9780841230910
Academic Journal
Stockley ML; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Ferdinand A; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Benedetti G; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Blencowe P; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Boyd SM; CompChem Solutions Ltd, St John's Innovation Centre, Cowley Rd, CambridgeCB4 0WS, U. K.; Calder M; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Charles MD; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Edwardes LV; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Ekwuru T; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Finch H; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Galbiati A; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Geo L; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Grande D; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Grinkevich V; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Holliday ND; Excellerate Bioscience Ltd., BioCity, Pennyfoot Street, NottinghamNG1 1GF, U. K.; Krajewski WW; Cancer Research Horizons Therapeutic Innovation, The Francis Crick Institute, 1 Midland Road, LondonNW1 1AT, U. K.; MacDonald E; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Majithiya JB; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; McCarron H; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; McWhirter CL; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Patel V; Excellerate Bioscience Ltd., BioCity, Pennyfoot Street, NottinghamNG1 1GF, U. K.; Pedder C; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Rajendra E; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Ranzani M; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Rigoreau LJM; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Robinson HMR; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Schaedler T; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Sirina J; Excellerate Bioscience Ltd., BioCity, Pennyfoot Street, NottinghamNG1 1GF, U. K.; Smith GCM; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.; Swarbrick ME; Cancer Research Horizons Therapeutic Innovation, Jonas Webb Building, Babraham Research Campus, CambridgeCB22 3AT, U. K.; Turnbull AP; Cancer Research Horizons Therapeutic Innovation, The Francis Crick Institute, 1 Midland Road, LondonNW1 1AT, U. K.; Willis S; Cancer Research Horizons Therapeutic Innovation, The Francis Crick Institute, 1 Midland Road, LondonNW1 1AT, U. K.; Heald RA; Artios Pharma Ltd., B940, Babraham Research Campus, CambridgeCB22 3FH, U. K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
ChemInform. 21
Academic Journal
Synlett. 1990:277-278
Academic Journal
Finlay MRV; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Anderton M; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Bailey A; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Boyd S; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Brookfield J; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Cairnduff C; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Charles M; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Cheasty A; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Critchlow SE; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Culshaw J; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Ekwuru T; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Hollingsworth I; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Jones N; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Leroux F; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Littleson M; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; McCarron H; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; McKelvie J; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Mooney L; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Nissink JWM; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Perkins D; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Powell S; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Quesada MJ; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Raubo P; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Sabin V; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Smith J; Cancer Research UK, Therapeutic Discovery Laboratories , Jonas Webb Building, Babraham Research Campus , Cambridge CB22 3AT , United Kingdom.; Smith PD; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Stark A; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Ting A; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Wang P; Pharmaron Beijing Co., Ltd. , 6 Taihe Road, BDA , Beijing 100176 , P. R. China.; Wilson Z; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Winter-Holt JJ; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Wood JM; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Wrigley GL; Oncology, IMED Biotech Unit , AstraZeneca , 310, Cambridge Science Park, Milton Road , Cambridge CB4 0FZ , United Kingdom.; Yu G; Pharmaron Beijing Co., Ltd. , 6 Taihe Road, BDA , Beijing 100176 , P. R. China.; Zhang P; Pharmaron Beijing Co., Ltd. , 6 Taihe Road, BDA , Beijing 100176 , P. R. China.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Charles MD; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Brookfield JL; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Ekwuru TC; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Stockley M; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Dunn J; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Riddick M; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Hammonds T; Cancer Research Technology Discovery Laboratories, London Bioscience Innovation Centre , Royal College Street, London NW1 0NH, U.K.; Trivier E; Cancer Research Technology Discovery Laboratories, London Bioscience Innovation Centre , Royal College Street, London NW1 0NH, U.K.; Greenland G; Cancer Research Technology Discovery Laboratories, London Bioscience Innovation Centre , Royal College Street, London NW1 0NH, U.K.; Wong AC; Cancer Research Technology Discovery Laboratories, London Bioscience Innovation Centre , Royal College Street, London NW1 0NH, U.K.; Cheasty A; Cancer Research Technology Discovery Laboratories , Jonas Webb Building, Babraham Research Campus, Cambridge CB22 3AT, U.K.; Boyd S; CompChem Solutions Ltd, St John's Innovation Centre , Cambridge CB4 0WS, U.K.; Crighton D; Beatson Institute, Cancer Research U.K. , Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.; Olson MF; Beatson Institute, Cancer Research U.K. , Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ekwuru, T.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어